Annexin V Release and Transmembrane Mitochondrial Potential during Storage of Apheresis-Derived Platelets Treated for Pathogen Reduction

Publisher： Karger

E-ISSN： 1660-3818|37|1|7-12

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.37, Iss.1, 2010-01, pp. : 7-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Metabolomic analysis of platelets during storage: a comparison between apheresis‐ and buffy coat–derived platelet concentrates

By  

TRANSFUSION, Vol. 55, Iss. 2, 2015-02 ,pp. : 301-313

John Wiley & Sons Inc

Access to resources Recommend Favorite

Storage Characteristics of Split Double-Dose Platelet Concentrates Derived from Apheresis and Treated with Amotosalen Hydrochloride and UVA Light for Pathogen Inactivation

By  

Transfusion Medicine and Hemotherapy, Vol. 29, Iss. 4, 2002-08 ,pp. : 193-198

Karger

Access to resources Recommend Favorite

Leukoreduced whole blood–derived platelets treated with antimicrobial peptides maintain in vitro properties during storage

By  

TRANSFUSION, Vol. 54, Iss. 6, 2014-06 ,pp. : 1604-1609

John Wiley & Sons Inc

Access to resources Recommend Favorite

Evaluation of Different Preparation Procedures of Pathogen Reduction Technology(Mirasol®)-Treated Platelets Collected by Plateletpheresis

By  

Transfusion Medicine and Hemotherapy, Vol. 36, Iss. 5, 2009-08 ,pp. : 309-315

Karger

Access to resources Recommend Favorite

Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions

By  

TRANSFUSION, Vol. 55, Iss. 7, 2015-07 ,pp. : 1745-1751

John Wiley & Sons Inc

Access to resources Recommend Favorite